Top Companies in Radiotherapy Market

The global radiotherapy market is expected to grow from USD 7.98 billion in 2026 to USD 10.68 billion by 2031, registering a CAGR of 6.0% during the forecast period. In the past ten years, there have been numerous technological innovations in the radiotherapy equipment market. These advancements have played a crucial role in enabling manufacturers to create more effective and user-friendly radiotherapy devices, delivering high-quality, precise radiation doses. Innovative technologies, such as intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and MRI-guided linear accelerators, have improved the precision of radiation treatments. Additionally, the use of AI-based software for treatment planning and automated image contouring is essential for enhancing the efficacy of radiotherapy.

The radiotherapy market is moderately competitive, with both well-established players and new entrants vying for market share. As of 2025, the major players in this market are Siemens Healthineers GmbH (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA WORLDWIDE (Belgium), ViewRay Technologies, Inc. (US), Perspective Therapeutics, Inc. (US), Hitachi High Tech Corporation (Japan), Sumitomo Heavy Industries Ltd. (Japan), Carl Zeiss Meditec AG (Germany), and Koninklijke Philips N.V. (Netherlands). These firms are currently creating advanced radiation therapy products to improve patient outcomes.

To know about the assumptions considered for the study download the pdf brochure

SIEMENS HEALTHINEERS AG (GERMANY)

Siemens Healthineers AG specializes in manufacturing and distributing medical equipment and services, including diagnostic equipment, laboratory diagnostics, imaging, and advanced radiotherapy solutions. The company operates through four key divisions: Imaging, Diagnostics, Varian, and Advanced Therapies. Its Varian division, which is a subsidiary, offers state-of-the-art medical solutions for radiotherapy, radiosurgery, and proton therapy. To expand its market presence, Siemens Healthineers focuses on both organic and inorganic growth strategies. Over the past three years, Varian has introduced several products, received regulatory approvals, and established numerous agreements, partnerships, collaborations, and contracts. Significant investment in research and development (R&D) within Varian ensures the delivery of cutting-edge solutions, such as MR-LINAC. The company has a strong global presence in over 70 countries and maintains its main production sites in the US, China, and Germany. Siemens Healthineers also boasts an extensive sales and distribution network spanning more than 180 countries, including Europe, the Americas, Asia Pacific, and the Middle East & Africa.

ELEKTA (SWEDEN)

Elekta is a manufacturer of oncological equipment that specializes in advanced radiation medicine. The company focuses on treatment solutions, including radiation therapies, radiosurgery, and information technology systems for cancer and neurology. Elekta's offerings include image-guided radiation therapy (IGRT), stereotactic radiosurgery, brachytherapy, and radiation oncology information systems for oncology clinics. Elekta operates through three main segments: Hardware, Software, and Services. It provides radiology products and techniques across all these segments. The company distributes its products in 120 countries across North and South America, Europe, the Middle East, Africa, and the Asia Pacific region, managing distribution directly. Elekta has several research and development (R&D) locations dedicated to various product lines, including Elekta Informatics Solutions (US and China), Leksell Gamma Knife (LGK) (Sweden), Brachytherapy products (Netherlands), and LINACs and MR-LINACs (Crawley, UK, and Beijing, China). Manufacturing facilities for Elekta are located in the UK (for LINACs and MR-LINACs), China (for LINACs and MR-LINACs), and the Netherlands (for Brachytherapy products).

ACCURAY INCORPORATED (US)

Accuray Incorporated is a global innovation company focused on developing and launching advanced radiotherapy solutions. The company's key products include CyberKnife, TomoTherapy systems, and Radixact systems. These innovative solutions enable the delivery of advanced treatments, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), and adaptive radiation therapy. Accuray is a leading player in the radiotherapy industry, with a strong market presence in over 50 countries. The company is committed to product innovation to maintain its position in the global radiotherapy market.

Related Reports:

Radiotherapy Market by Technology (EBRT: LINAC, Stereotactic, Particle; Internal Beam/Brachytherapy, Cobalt-60 Teletherapy), Procedure (IGRT, IMRT, 3D-CRT, LDR, PDR), Cancer (Prostate, Lung, Breast, CRC), End User (Hospital, IRC) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]